ACS Surgery News will be in Las Vegas this week at the annual meeting of the American Society of Breast Surgeons reporting on the latest in multidisciplinary management of benign and not-so-benign breast disease. Our reporters will cover controversies in neoadjuvant therapy, including managing axilla and skipping surgery with biopsy proven pathological complete response (pCR), as well as the use of axillary ultrasound on a clinically negative axilla, and what to do for in situ carcinoma and borderline cases. Coverage will also include the latest updates in high-risk and genetic predisposition, breast cancer subtypes, lymphedema, and recurrent and metastatic breast cancer, and guidance for coding and reimbursement.
Highly anticipated presentations include:
• Many Women are Choosing Unnecessarily Radical Surgeries for Early-Stage Cancer
• Debunking the Myth of Lymphedema Risk
• Aggressive Inflammatory Breast Cancer Treatment Yields Low Local/Regional Recurrence
Our team will provide daily coverage, beginning Thursday, April 27.